Impact of Nirsevimab on Respiratory Syncytial Virus <scp>PCR</scp> Test Positivity in Young Infants: A Community‐Level Observational Study in Queensland, Australia

20260 citationsJournal Articlehybrid Open Access

Authors

Asmaa El‐Heneidy · Griffith University

Keith Grimwood · Griffith University

Jennifer Robson · Sullivan Nicolaides Pathology

Chanpaseuth Vicki Vilaylath · Sullivan Nicolaides Pathology

Sarah G. Cherian · Sullivan Nicolaides Pathology

Stephen B. Lambert · The University of Queensland

Robert S. Ware

Abstract

We present the first real-world community-based evidence on the impact of nirsevimab upon RSV detection percentages in infants aged ≤ 3 months in Queensland, Australia. The nirsevimab-based prevention program may be contributing to a substantial decline in RSV detection percentages among young infants in the community.

Topics & Keywords

Respiratory viral infections research Virology and Viral Diseases SARS-CoV-2 detection and testing

Publication Details

Published in: Journal of Paediatrics and Child Health

Volume 62, Issue 4, pp. 614-620

DOI: 10.1111/jpc.70317

Field-Weighted Citation Impact: 0.00

Command Palette

Impact of Nirsevimab on Respiratory Syncytial Virus <scp>PCR</scp> Test Positivity in Young Infants: A Community‐Level Observational Study in Queensland, Australia

Authors

Abstract

Topics & Keywords

Publication Details